Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Lupus Nephritis, or a Mimic?

Matthew J. Mandell, DO, FACP, Yishui Chen, MD, Prerna Rastogi, MD, PhD, & Rebecca Tuetken, MD, PhD  |  May 31, 2025

At his one-month outpatient follow- up, his edema, headache, arthralgias, malaise, rash and diarrhea had all resolved. His cholesterol had normalized with statin therapy. Repeat urinalysis showed no blood and no protein, and the random urine-to-protein-creatine ratio had completely normalized (0.08 g/g Cr). His serum creatine declined to 1.2 mg/ dL. His inflammatory markers had also completely normalized (ESR 1 and CRP <0.5 mg/dL), as had his alkaline phosphatase and albumin.

Discussion

Searching PubMed, we identified only one case of co-infection with syphilis and parvovirus B19 mimicking lupus nephropathy, as in our patient.1 Parvovirus B19 and especially syphilis have been reported to cause the same histologic features of lupus nephritis—or so-called pseudolupus nephritis. Although the presence of C1q deposits is nearly pathognomonic for lupus nephritis, it can also be seen when parvovirus B19 causes kidney disease.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Our patient’s positive ANA and full-house pattern on renal biopsy pointed toward lupus nephritis; however, the discordant findings of negative double-stranded DNA and anti-Smith antibodies, lack of cytopenias, normal complements and lack of other clinical features of systemic lupus erythematosus made us question the diagnosis.

Syphilis fit the clinical schema well—and it should be noted that our patient’s mild hepatitis, with isolated elevation of alkaline phosphatase, is very characteristic of syphilitic hepatitis.2 The presence of C1q deposition in the kidney prompted us to check for parvovirus B19 antibodies, which came back suggestive of acute infection. This likely explained his symptoms of malaise and arthralgias, as well as skin redness/rash (which was not appreciated on admission when we evaluated the patient, several weeks after symptom onset). Other masqueraders of lupus nephritis include HIV and infective endocarditis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Syphilis has been historically referred to as the great mimicker given its heterogenous presentation.3,4 The three stages of infection are: primary, secondary and tertiary. Our patient likely had secondary infection, with rash and lymphadenopathy. Renal involvement can occur at any stage, from secondary to latent and tertiary. Both SLE and syphilis can have multi-system involvement.

This case illustrates the importance of thinking about infectious etiologies for glomerulonephritis and completing a thorough sexual history. Further, the diagnosis of lupus nephritis should be questioned when serologic and other laboratory markers (e.g., anti-Smith and double-stranded DNA antibodies, low complement levels, cytopenias) and clinical manifestations of lupus are absent, despite suggestive renal histology findings. The presence of C1q is nearly pathognomonic for lupus nephritis, but can also be seen when parvovirus B19 causes kidney disease.1 Parvovirus B19 and syphilis have been reported to cause the same histologic features of lupus nephritis.1,3,4-6

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:case reportLupus nephritis supplementparvovirus B19syphilis

Related Articles

    Case Report: Lupus Nephritis or a Mimic?

    November 10, 2022

    Syphilis, an ancient disease caused by the spirochete Treponema pallidum, has been historically referred to as the great mimicker given its heterogenous presentation. Both systemic lupus erythematosus (SLE) and syphilis can have multi-systemic involve­ment. Both parvovirus B19 and syphilis have been reported to cause histologic features similar to those seen in lupus nephritis.  We present…

    A Case of Lupus Podocytopathy

    June 17, 2024

    Kidney involvement is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). Collectively termed lupus nephritis, SLE with kidney involvement comes in many subtypes. The current classification by the International Society of Nephrology/Renal Pathology Society (ISN/RPS), however, does not include lupus podocytopathy, which, through various clinical and epidemiologic studies, has recently been…

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

    Tacrolimus Use for Lupus Nephritis Raises Debate over Role in North American Population

    October 10, 2016

    The following summary regarding use of tacrolimus (TAC) in lupus nephritis highlights a number of debatable points. Although the role of TAC in lupus nephritis remains unproved for North American populations, it might be an excellent option in some clinical situations. These situations include lupus flare during pregnancy and also for lupus nephritis when the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences